10 October 2025
Harena Resources Plc
("Harena" or the "Company")
Media Interview Now Available Online
Harena Resources Plc (LSE: HREE), the rare earths company developing the Ampasindava Ionic Clay Rare Earth Project in Madagascar, is pleased to share a recent media interview featuring Executive Chairman Ivan Murphy.
The interview covers key updates on:
|
• |
Progress toward the Pre-Feasibility Study (PFS) submission |
|
• |
Strategy for securing a full Mining Licence in Madagascar |
|
• |
Recent £450,000 investment from RAB Capital |
|
• |
Escalating global trade tensions over rare earths |
|
• |
Harena's positioning as a non-Chinese source of magnet metals |
Media Link:
Proactive Investors Interview with Ivan Murphy
Ivan outlines the strategic roadmap for Harena and the broader market context
https://www.youtube.com/watch?v=EL4EiyUcG1Q
For further information please contact:
|
Harena Resources Plc Allan Mulligan, Executive Technical Director |
+44 (0)20 7770 6424 LEI: 213800TNHZOA4JIZK687 |
|
Allenby Capital Limited - Financial Adviser & Joint Broker Jeremy Porter / Vivek Bhardwaj (Corporate Finance) Amrit Nahal / Kelly Gardiner (Sales & Corporate Broking) |
+44 (0)20 3328 5656 |
|
Tavira Financial Limited - Joint Broker Jonathan Evans / Oliver Stansfield |
+44 (0)20 7330 1833 |
|
Celicourt Communications - Public Relations Mark Antelme / Charles Denley-Myerson |
44 (0)20 7770 6424 celicourt@celicourt.uk |
Notes to editors
Harena (www.harenaresources.com.au) is a rare earths exploration and development company focused on the Ampasindava Ionic Clay Rare Earth Project in Madagascar (Harena's interest is 75%). The project hosts one of the largest ionic clay rare earth deposits outside of China, with significant concentrations of high-value magnet metals. Harena is committed to low-impact, high recovery mining, providing a sustainable supply of critical minerals for the global energy transition and military defence industries. Forward-Looking Statements This announcement contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those expressed or implied in such statements.